Tencent has begun a clinical trial in London of an artificial intelligence program that aims to diagnose patients with Parkinson’s disease, in partnership with a little-known British start-up called Medopad.
The tech giant was asked two years ago by the Chinese government to lead efforts to develop AI programs for medical diagnosis.
Trials coming from Zhittya 
Zhittya Genesis Medicine
is this dyskinesia or Parkinson’s?
Report on a Cleveland Clinic study involving the Pedaling for Parkinson's program (Jay Alberts et al.)
Parkinson’s and Radon
